BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24481878)

  • 21. Identification of miR-125b targets involved in acute promyelocytic leukemia cell proliferation.
    Zhang Y; Zeng C; Lu S; Qin T; Yang L; Chen S; Chen J; Li Y
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1758-63. PubMed ID: 27613090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Cell Type-Specific Effects of MicroRNA-92a Provides Novel Insights Into Target Regulation and Mechanism of Action.
    Rogg EM; Abplanalp WT; Bischof C; John D; Schulz MH; Krishnan J; Fischer A; Poluzzi C; Schaefer L; Bonauer A; Zeiher AM; Dimmeler S
    Circulation; 2018 Nov; 138(22):2545-2558. PubMed ID: 30571345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA.
    Bousquet M; Nguyen D; Chen C; Shields L; Lodish HF
    Haematologica; 2012 Nov; 97(11):1713-21. PubMed ID: 22689670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between miR-17-5p, miR-92a, and let-7b expression with non-small cell lung cancer targeted drug resistance.
    Gong J; He L; Ma J; Zhang J; Wang L; Wang J
    J BUON; 2017; 22(2):454-461. PubMed ID: 28534369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells.
    Lee KH; Chang MY; Ahn JI; Yu DH; Jung SS; Choi JH; Noh YH; Lee YS; Ahn MJ
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1125-33. PubMed ID: 12207890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The c-Myc-regulated miR-17-92 cluster mediates ATRA-induced APL cell differentiation.
    Yu X; Hu Y; Wu Y; Fang C; Lai J; Chen S; Li Y; Zeng C; Zeng Y
    Asia Pac J Clin Oncol; 2019 Dec; 15(6):364-370. PubMed ID: 31264378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-520a-5p displays a therapeutic effect upon chronic myelogenous leukemia cells by targeting STAT3 and enhances the anticarcinogenic role of capsaicin.
    Kaymaz BT; Cetintaş VB; Aktan C; Kosova B
    Tumour Biol; 2014 Sep; 35(9):8733-42. PubMed ID: 24870597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN.
    Liu D; Zhong L; Yuan Z; Yao J; Zhong P; Liu J; Yao S; Zhao Y; Liu L; Chen M; Li L; Liu B
    Cell Signal; 2019 Feb; 54():1-9. PubMed ID: 30453015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-20a inhibition using locked nucleic acid (LNA) technology and its effects on apoptosis of human macrophages infected by Toxoplasma gondii RH strain.
    Rezaei F; Daryani A; Sharifi M; Sarvi S; Jafari N; Pagheh AS; Hashemi N; Hejazi SH
    Microb Pathog; 2018 Aug; 121():269-276. PubMed ID: 29800695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of
    Drobna M; Szarzyńska B; Jaksik R; Sędek Ł; Kuchmiy A; Taghon T; Van Vlierberghe P; Szczepański T; Witt M; Dawidowska M
    Cells; 2020 May; 9(5):. PubMed ID: 32380791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of miR-34a-5p, miR-20a-3p and miR-29a-3p by Onconase in A375 Melanoma Cells Correlates with the Downregulation of Specific Onco-Proteins.
    De Tomi E; Campagnari R; Orlandi E; Cardile A; Zanrè V; Menegazzi M; Gomez-Lira M; Gotte G
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-143 regulates proliferation and apoptosis of myelocytic leukemia cell HL-60 via modulating ERK1.
    Song B; Tang YJ; Zhang WG; Wan CC; Chen Y; Zhang LJ
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3333-3341. PubMed ID: 29917183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-140-5p and miR-92a-3p suppress the cell proliferation, migration and invasion and promoted apoptosis in Wilms' tumor by targeting FRS2.
    Li JL; Luo P
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):97-108. PubMed ID: 31957822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-181a down-regulates MAP2K1 to enhance adriamycin sensitivity in leukemia HL-60 cells.
    Wang JJ; Yu JP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2497-2504. PubMed ID: 30964176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.
    Ke S; Li RC; Lu J; Meng FK; Feng YK; Fang MH
    Int J Hematol; 2017 Aug; 106(2):258-265. PubMed ID: 28409330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice.
    Li Y; Vecchiarelli-Federico LM; Li YJ; Egan SE; Spaner D; Hough MR; Ben-David Y
    Blood; 2012 May; 119(19):4486-98. PubMed ID: 22451425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia.
    Zhang H; Luo XQ; Feng DD; Zhang XJ; Wu J; Zheng YS; Chen X; Xu L; Chen YQ
    Mol Cancer; 2011 Sep; 10():108. PubMed ID: 21880154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia.
    Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs contribute to promyelocyte apoptosis in As2O3-treated APL cells.
    Liang H; Li X; Wang L; Yu S; Xu Z; Gu Y; Pan Z; Li T; Hu M; Cui H; Liu X; Zhang Y; Xu C; Guo R; Lu Y; Yang B; Shan H
    Cell Physiol Biochem; 2013; 32(6):1818-29. PubMed ID: 24356076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of miR-504-3p is associated with favorable prognosis of acute myeloid leukemia and may serve as a tumor suppressor by targeting MTHFD2.
    Li SM; Zhao YQ; Hao YL; Liang YY
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1203-1213. PubMed ID: 30779090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.